
Coumarin343
CAS No. 55804-65-4
Coumarin343( —— )
Catalog No. M36948 CAS No. 55804-65-4
Coumarin343 inhibits monocarboxylic acid transporter protein 4 with IC50 values in the range of 0.01-100 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 38 | In Stock |
![]() ![]() |
100MG | 59 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCoumarin343
-
NoteResearch use only, not for human use.
-
Brief DescriptionCoumarin343 inhibits monocarboxylic acid transporter protein 4 with IC50 values in the range of 0.01-100 μM.
-
DescriptionCoumarin 343 (C343) is a hydrophilic fluorescent probe for the micro water pool. λem is approximately 425 nm andλem is approximately from 425 nm to 550 nm by RF-1500.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonocarboxylate Transporter
-
RecptorMonocarboxylate transporter | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55804-65-4
-
Formula Weight285.29
-
Molecular FormulaC16H15NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)c1cc2cc3CCCN4CCCc(c34)c2oc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Keiju Yamazaki, et al. Fluorometric analysis on physicochemical properties of phosphatidylcholine-based W/O microemulsion involved with enzymatic reactivity in phospholipid hydrolysis. Korean Journal of Chemical Engineering volume 25, pages 1439–1443 (2008).
molnova catalog



related products
-
BAY8002
BAY-8002 is a potent dual MCT1/2 inhibitor (IC50 values are 3 8 and 12 nM at rat (C6) human (DLD-1) and mouse (4T1) MCT1 respectively).
-
MSC-4381
MSC-4381 (MCT4-IN-1) is an orally available and selectively modeled highly potent inhibitor of monocarboxylic acid transporter protein 4 (MCT4/SLC16A3) with potential anticancer and antitumor activity for the study of osteosarcoma.
-
MCT1-IN-3
MCT1-IN-3 is a monocarboxylate transporter 1 (MCT1) inhibitor, targeting solute carrier (SLC) monocarboxylate transporter 1 (MCT1; SLC16A1) for cancer treatment.